Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV.
- DOI
- 10.3390/pharmaceutics16050594
- Published
- 2024 Apr 27
- Container
- Pharmaceutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics16050594,
title = {Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV.},
author = {Mayer BT and Zhang L and deCamp AC and Yu C and Sato A and Angier H and Seaton KE and Yates N and Ledgerwood JE and Mayer K and Caskey M and Nussenzweig M and Stephenson K and Julg B and Barouch DH and Sobieszczyk ME and Edupuganti S and Kelley CF and McElrath MJ and Gelderblom HC and Pensiero M and McDermott A and Gama L and Koup RA and Gilbert PB and Cohen MS and Corey L and Hyrien O and Tomaras GD and Huang Y},
year = {2024},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics16050594},
url = {https://doi.org/10.3390/pharmaceutics16050594}
}RIS
TY - JOUR TI - Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV. AU - Mayer BT AU - Zhang L AU - deCamp AC AU - Yu C AU - Sato A AU - Angier H AU - Seaton KE AU - Yates N AU - Ledgerwood JE AU - Mayer K AU - Caskey M AU - Nussenzweig M AU - Stephenson K AU - Julg B AU - Barouch DH AU - Sobieszczyk ME AU - Edupuganti S AU - Kelley CF AU - McElrath MJ AU - Gelderblom HC AU - Pensiero M AU - McDermott A AU - Gama L AU - Koup RA AU - Gilbert PB AU - Cohen MS AU - Corey L AU - Hyrien O AU - Tomaras GD AU - Huang Y PY - 2024 JO - Pharmaceutics DO - 10.3390/pharmaceutics16050594 UR - https://doi.org/10.3390/pharmaceutics16050594 ER -
APA
BT, M., L, Z., AC, D., C, Y., A, S., H, A., KE, S., N, Y., JE, L., K, M., M, C., M, N., K, S., B, J., DH, B., ME, S., S, E., CF, K., MJ, M., HC, G., M, P., A, M., L, G., RA, K., PB, G., MS, C., L, C., O, H., GD, T., & Y, H. (2024). Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics16050594
Source records
- pubmed · retrieved 2026-09-26T20:32:02.985Z